17-Jul-2014 - Siemens AG

Siemens Healthcare agrees to sell microbiology business to Beckman Coulter

Stronger concentration of Diagnostics Division on core business

Siemens Healthcare is selling its microbiology business to Beckman Coulter Inc., a wholly owned subsidiary of Danaher Corporation. The activities of the microbiology business include systems for the identification and antibiotic susceptibility testing (ID/AST) of microorganisms. The decision enables Siemens Healthcare to focus on its core in-vitro business within the Diagnostics Division and is also in alignment with Siemens – Vision 2020. It has been agreed not to disclose details of this transaction. The transaction is subject to applicable regulatory approvals..

Facts, background information, dossiers
  • Siemens
  • microbiology
  • Beckman Coulter
  • dagnostics
More about Siemens
More about Beckman Coulter